Hyperprolactinemia: Causes, Symptoms, and Treatment Options

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Hyperprolactinemia, characterized by elevated prolactin levels, can manifest with diverse symptoms affecting reproductive, sexual, and general health. Its causes range from physiological factors to pituitary tumors and medication side effects. Accurate diagnosis and tailored treatment are crucial for managing this condition and improving patient quality of life.

Hyperprolactinemia: Causes, Symptoms, and Treatment Options

Hyperprolactinemia is an endocrine disorder defined by abnormally high levels of prolactin in the blood. Prolactin, a hormone produced by the pituitary gland, is primarily known for its role in stimulating milk production (lactation) in women after childbirth. However, it also plays a part in reproductive function, metabolism, and immune regulation in both sexes. When prolactin levels become excessively elevated, they can disrupt hormonal balance and lead to a wide array of clinical manifestations, impacting fertility, sexual health, and overall well-being.

Normal Prolactin Levels:

Normal prolactin levels typically range from:

• Men: 2-18 ng/mL (or µg/L)
• Non-pregnant, non-lactating women: 2-25 ng/mL (or µg/L)

Levels consistently above these ranges warrant investigation.

Causes of Hyperprolactinemia:

The etiology of hyperprolactinemia is diverse and can be broadly categorized:

1. Physiological Causes: These are normal, non-pathological elevations.
   • Pregnancy and Lactation: The most common physiological cause.
   • Stress: Physical (e.g., intense exercise, chest wall trauma, surgery) and psychological stress can transiently elevate prolactin.
   • Sleep: Prolactin levels naturally rise during sleep.
   • Sexual Intercourse: Can cause a transient increase.
2. Pathological Causes: These involve underlying medical conditions.
   • Prolactinomas: These are benign tumors (adenomas) of the pituitary gland that autonomously produce and secrete excessive amounts of prolactin. They are the most common cause of persistent hyperprolactinemia. Microprolactinomas are <10 mm, while macroprolactinomas are ≥10 mm.
   • Other Pituitary Tumors: Non-prolactin-secreting pituitary tumors can compress the pituitary stalk, disrupting the flow of dopamine from the hypothalamus to the pituitary. Since dopamine inhibits prolactin release, this "stalk effect" can lead to hyperprolactinemia.
   • Hypothyroidism: An underactive thyroid gland can lead to increased Thyrotropin-Releasing Hormone (TRH), which can stimulate prolactin release.
   • Chronic Kidney Disease: Reduced renal clearance of prolactin can lead to elevated levels.
   • Liver Disease: Impaired prolactin metabolism.
   • Polycystic Ovary Syndrome (PCOS): Some women with PCOS may have mild hyperprolactinemia.
   • Idiopathic Hyperprolactinemia: Elevated prolactin without an identifiable cause after thorough investigation.
3. Pharmacological Causes (Drug-Induced): Many medications can interfere with dopamine synthesis, release, or receptor binding, leading to hyperprolactinemia. Common culprits include:
   • Antipsychotics: Especially first-generation (e.g., haloperidol) and some second-generation (e.g., risperidone, paliperidone).
   • Antidepressants: Certain SSRIs and tricyclic antidepressants.
   • Antihypertensives: Verapamil, methyldopa.
   • Gastrointestinal Prokinetics: Metoclopramide, domperidone.
   • Opioids.
   • Estrogens: High doses.

Symptoms of Hyperprolactinemia:

Symptoms vary depending on sex, age, and the degree and duration of prolactin elevation. They often arise from hypogonadism (low sex hormones) and direct prolactin effects.

• In Women:
  • Menstrual Irregularities: Oligomenorrhea (infrequent periods), amenorrhea (absence of periods).
  • Galactorrhea: Spontaneous milk production unrelated to childbirth or breastfeeding (present in 30-80% of cases).
  • Infertility: Due to anovulation.
  • Reduced Libido and Dyspareunia: Painful intercourse due to vaginal dryness.
  • Osteopenia/Osteoporosis: Long-term estrogen deficiency.
• In Men:
  • Reduced Libido: Decreased sex drive.
  • Erectile Dysfunction (ED): Difficulty achieving or maintaining erections.
  • Infertility: Due to impaired spermatogenesis.
  • Gynecomastia: Breast tissue enlargement (less common than in women).
  • Reduced Muscle Mass and Bone Density: Due to low testosterone.
• In Both Sexes:
  • Headaches and Visual Disturbances: Particularly with larger pituitary tumors (macroprolactinomas) compressing surrounding structures.
  • Fatigue and Mood Changes.

Treatment Options:

Treatment is tailored to the underlying cause and severity of symptoms.

1. Dopamine Agonists: These are the first-line treatment for prolactinomas and idiopathic hyperprolactinemia. They mimic dopamine, suppressing prolactin secretion and often shrinking tumors.
   • Cabergoline (Dostinex): Preferred due to its higher efficacy, better tolerability, and less frequent dosing (typically 0.25-1 mg once or twice weekly).
   • Bromocriptine (Parlodel): Older agent, often less well-tolerated due to more side effects and daily dosing.
2. Medication Adjustment: If drug-induced, discontinuing or switching the offending medication (if clinically feasible) can resolve hyperprolactinemia.
3. Thyroid Hormone Replacement: For hypothyroidism, levothyroxine therapy will normalize prolactin.
4. Surgery: Transsphenoidal surgery may be considered for macroprolactinomas unresponsive to dopamine agonists, or for those causing severe visual field defects.
5. Radiation Therapy: A less common option, reserved for aggressive or recurrent tumors not controlled by other means.

Regular monitoring of prolactin levels, symptoms, and pituitary imaging (if applicable) is essential during treatment to ensure efficacy and adjust therapy as needed. With appropriate management, most individuals with hyperprolactinemia can achieve normal prolactin levels and resolution of symptoms.